2 Heteroaryl 3 Oxo 2,3 Dihydropyridazine 4 Carboxamides For The Treatment Of Cancer


Updated over 1 year ago

Abstract

The present invention covers 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamide compounds of general formula (I), in which X, R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of cancer or conditions with dysregulated immune responses or other disorders associated with aberrant AHR signaling, as a sole agent or in combination with other active ingredients.

Information

Application ID 201917031626
Invention Field CHEMICAL
Date of Application 2019-08-05
Publication Number 36/2019

Applicants

Name Address Country Nationality
BAYER AKTIENGESELLSCHAFT Kaiser-Wilhelm-Allee 1 51373 Leverkusen Germany Germany
BAYER PHARMA AKTIENGESELLSCHAFT Müllerstr. 178 13353 Berlin Germany Germany
DEUTSCHES KREBSFORSCHUNGSZENTRUM Im Neuenheimer Feld 280 69120 Heidelberg Germany Germany

Inventors

Name Address Country Nationality
GUTCHER, Ilona Paul-Robeson-Str. 28 10439 Berlin Germany BRITISH ISLES
RÖHN, Ulrike Boyenstr. 42 10115 Berlin Germany Germany
SCHMEES, Norbert Bondickstr. 61 13469 Berlin Germany Germany
ZORN, Ludwig Osianderweg 45A 13509 Berlin Germany Germany
RÖSE, Lars Fuchsring 82 13465 Berlin France Germany
BADER, Benjamin Hillmannstr. 14 13467 Berlin Germany Germany
KOBER, Christina Am Alten Bahnhof 8 35457 Lollar Germany Germany
CARRETERO, Rafael Mühlingstr. 6 69121 Heidelberg Germany Spain
STÖCKIGT, Detlef Clara-Zetkin-Str. 27 14471 Potsdam Germany Germany
IRLBACHER, Horst Winsstr. 47 10405 Berlin Germany Germany
PLATTEN, Michael Cambridgestr. 7 69115 Heidelberg Germany Germany

Specification

Documents

Name Date
201917031626-CLAIMS [02-07-2021(online)].pdf 2021-07-02
201917031626-COMPLETE SPECIFICATION [05-08-2019(online)].pdf 2019-08-05
201917031626-Correspondence-260819.pdf 2019-08-28
201917031626-DECLARATION OF INVENTORSHIP (FORM 5) [05-08-2019(online)].pdf 2019-08-05
201917031626-DRAWINGS [05-08-2019(online)].pdf 2019-08-05
201917031626-DRAWING [02-07-2021(online)].pdf 2021-07-02
201917031626-FER.pdf 2021-10-18
201917031626-FER_SER_REPLY [02-07-2021(online)].pdf 2021-07-02
201917031626-FORM-26 [23-08-2019(online)].pdf 2019-08-23
201917031626-FORM 18 [05-02-2021(online)].pdf 2021-02-05
201917031626-FORM 1 [05-08-2019(online)].pdf 2019-08-05
201917031626-FORM 3 [05-02-2021(online)].pdf 2021-02-05
201917031626-FORM 3 [13-05-2020(online)].pdf 2020-05-13
201917031626-FORM 3 [16-05-2020(online)].pdf 2020-05-16
201917031626-PETITION UNDER RULE 137 [02-07-2021(online)].pdf 2021-07-02
201917031626-Power of Attorney-260819.pdf 2019-08-28
201917031626-PRIORITY DOCUMENTS [05-08-2019(online)].pdf 2019-08-05
201917031626-Response to office action [06-12-2021(online)].pdf 2021-12-06
201917031626-SEQUENCE LISTING [05-08-2019(online)].pdf 2019-08-05
201917031626-SEQUENCE LISTING(PDF) [05-08-2019(online)].pdf 2019-08-05
201917031626-STATEMENT OF UNDERTAKING (FORM 3) [05-08-2019(online)].pdf 2019-08-05
201917031626-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [05-08-2019(online)].pdf 2019-08-05
abstract.jpg 2019-08-28

Orders

Applicant Section Controller Decision Date URL